CLREX | RLBCX | CLREX / RLBCX | |
Total Expense Ratio | 0.65 | 0.89 | 73% |
Annual Report Gross Expense Ratio | 0.65 | 0.89 | 73% |
Fund Existence | 15 years | 23 years | - |
Gain YTD | 8.958 | 9.861 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 10.1B | 256B | 4% |
Annual Yield % from dividends | 1.87 | 1.53 | 122% |
Returns for 1 year | 5.72 | 8.12 | 70% |
Returns for 3 years | 34.56 | 36.23 | 95% |
Returns for 5 years | 26.95 | 36.33 | 74% |
Returns for 10 years | 75.34 | 72.59 | 104% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EPS | 67.09 | 0.40 | +0.60% |
WisdomTree U.S. LargeCap Fund | |||
BMED | 26.34 | 0.05 | +0.18% |
iShares Health Innovation Active ETF | |||
NCZ | 13.49 | 0.01 | +0.07% |
Virtus Convertible & Income Fund II | |||
ASEA | 17.18 | -0.04 | -0.23% |
Global X FTSE Southeast Asia ETF | |||
MVLL | 13.32 | -1.02 | -7.11% |
GraniteShares 2x Long MRVL Daily ETF |